Bottom line is all these new products are hitting also.. We didn't get many fluticasone revenues the 1st quarter, but will have many many fluticasone sales the 2nd quarter, along with the regular good sellers. I totally believe we will hit the 4.5 million dollar revenue target for 2nd quarter sales, then as fluticasone sales will probably decrease a bit in the 3rd quarter for seasonal reasons(allergy season has peaked now) but the new diabetic products and other new products could easily propel Revenues into the 5 million per quarter range or more....
So if that is the case, and we get at least 9 million in revenues booked for 1st half, and 10 million in revenue for 2nd half, it's a cinch that over 1 million in excess revenues will be booked for 2018... And remember, if they were to slow the advertising and promotion spending in the 4th quarter, I believe with the 80% gross profit margins, it will be easy to show NET PROFITS for the 4th quarter...
Everything looks good imo for the rest of the year! I'm still accumulating these cheap cheap tickets.... GLTA
